Source: International Congress 2015 – Clinical problems in acute and chronic lung diseases
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Yu Mikami (Tokyo, Japan), Yu Mikami, Daiya Takai, Masafumi Horie, Satoshi Noguchi, Hirotaka Matsuzaki, Kosuke Makita, Hideyuki Takeshima, Yasuhiro Yamauchi, Go Tanaka, Takahide Nagase. Respiratory manifestations in hospitalized patients with hematological malignancies. Eur Respir J 2015; 46: Suppl. 59, 2907

Member's Comments

No comment yet.

Related content which might interest you: The role of flexible bronchoscopy in the evaluation of fever in immunocompromised haematological patients Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014 Pulmonary complications in patients with hematologic diseases Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach Year: 2012 Outcome and prognostic features in respiratory critically-ill patients with hematological malignancies Source: International Congress 2015 – Acute critical care: novelties in critical care Year: 2015 Clinical characteristics and prognosis of chronic pulmonary aspergillosis Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014 Clinical characteristics of pulmonary nocardiosis in immunocompetent patients Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical and functional characterisation Year: 2015 Clinical and radiological features of pneumocystis pneumonia in immunocompromised non-HIV patients Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections Year: 2016 Safety and usefulness of bronchoscopy in patients with hematological disorders Source: Annual Congress 2013 –New treatments and old dilemmas in the clinical management of lung diseases Year: 2013 Features of systemic inflammation in patients with severe community-acquired (CAP) pneumonia of different etiology in HIV-infected patients Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015 Is bronchoscopy essential for pulmonary infections in patients with haematological malignancies? Source: Breathe, 16 (4) 200268; 10.1183/20734735.0268-2020 Year: 2020 Clinical features of invasive bronchial-pulmonary aspergillosis in critically ill patients with chronic respiratory diseases: a prospective study Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus Year: 2009 Diagnosis and outcome of acute respiratory failure in immunocompromised patients after bronchoscopy Source: Eur Respir J, 54 (1) 1802442; 10.1183/13993003.02442-2018 Year: 2019 Impact of comorbidities and etiology of bronchiectasis on outcomes in hospitalised patients with bronchiectasis Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 Predictors of exacerbations in patients with bronchiectasis Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014 Exacerbations of bronchiectasis requiring hospitalization; clinical characteristics and outcomes Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations Year: 2016 The prevalence of cardiac diseases in patients with community-acquired pneumonia Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014 Respiratory infections in transplant patients Source: Annual Congress 2008 - PG18 - Respiratory infections in immunosuppressed children Year: 2008 Clinical characteristics of chronic pulmonary aspergillosis and colonization; retrospective analysis of patients with isolation of asperguillus species from respiratory samples Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014 Pro: Bronchoscopy is essential for pulmonary infections in patients with haematological malignancies Source: Breathe, 16 (4) 200228; 10.1183/20734735.0228-2020 Year: 2020